ERR open access journal advertisement
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

EUROPEAN RESPIRATORY REVIEW, 2005;14: 51-56. doi:10.1183/09059180.05.00009502
© 2005 the European Respiratory Society
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivieri, D.
Right arrow Articles by Scoditti, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olivieri, D.
Right arrow Articles by Scoditti, E.

Impact of environmental factors on lung defences

D. Olivieri and E. Scoditti

Dept of Clinical Sciences, Section of Respiratory Disease, University of Parma, Italy.

CORRESPONDENCE: D. Olivieri, Clinica Pneumologica, Ospedale Rasori, Via Rasori, 10, 43100 Parma, Italy. Fax: 39 0521292615. E-mail: dario.olivieri{at}unipr.it


   ABSTRACT
TOP
 ABSTRACT
OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
The lungs are one of the most important organs exposed to environmental agents. The lungs have the ability to protect themselves by both immunological and nonimmunological mechanisms. An individual's susceptibility to the impact of environmental agents will determine their adverse effects.

This article focuses on air pollution, in particular ozone (O3), nitrogen dioxide (NO2), particulate matter (PM) and sulphur dioxide (SO2). O3 inhalation first modifies the ciliary cells. O3 is an extremely strong oxidant, since it increases the permeability of epithelial cells and decreases mucociliary clearance. NO2 is a less potent and less reactive oxidant pollutant and impairs the function of epithelial cells and alveolar macrophages. PM induces oxidative stress in macrophages and epithelial cells, and increases tumour necrosis factor-ß, interleukin (IL)-6, interferon-{gamma}, transforming growth factor-ß and nuclear factor-B. Diesel exhaust particulate, contained in PM, increases IL-8 production. High concentrations of SO2 increase the production of reactive oxygen species in the lungs.

In conclusion, air pollution certainly interferes with aspecific and specific lung defences, thus facilitating the development of pulmonary diseases, such as exacerbation of chronic obstructive pulmonary disease, allergies and asthma.

KEYWORDS: Air pollution, environmental factors, lung defences, mucociliary clearance, ozone, particulate matter

The lung is one of the most important organs exposed to environmental agents [1]. Airway injury is caused by multiple factors that vary both in their nature and effect [2]. In this article "air pollution", a term encompassing a wide range of chemical and biological components in the outdoor and indoor atmosphere, including environmental tobacco smoke (ETS), is examined [3]. Outdoor air pollutants that are hazardous for the respiratory tract are gaseous chemicals (nitrogen dioxide (NO2), ozone (O3), sulphur dioxide (SO2)), inhaled particulate matter (PM) and aeroallergens, such as those derived from fungal spores and allergenic pollen. Indoor air contains a range of noxious substances derived from a multitude of sources. Outdoor pollutants can also affect indoor air. Present in the home are ETS, NO2, formaldehyde (HCHO) and other volatile organic compounds (VOCs), as well as PM, SO2, O3 and allergens derived from a diverse range of plants, animals and insects.

The ability of the lungs to protect themselves by both immunological and nonimmunological mechanisms and the individual's susceptibility to their impact will determine the outcome in terms of their adverse effects [4]. This paper focuses on NO2, O3 and PM in the atmosphere of urban areas, and SO2 in industrial areas, because of their particular action on lung defences (table 1Go).


View this table:
[in this window]
[in a new window]
  		TABLE 1— Main environmental factors having impact on lung defences

 

   OZONE
TOP
 ABSTRACT
 OZONE
NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
O3 is generated at ground level by a photochemical reaction between ultraviolet radiation and atmospheric mixtures of NO2 and hydrocarbons derived from vehicle emissions. O3 levels depend on NO2 emitted by cars and particularly on sunny weather that transforms NO2 into O3. O3 is the most important factor for summer smog, because it accounts for up to 90% of total oxidant levels in cities that enjoy a mild sunny climate.

Short-term O3 inhalation first modifies the ciliary cells, which seem to be the most sensitive. The clara cells then undergo degranulation and destruction, while the reorganisation of the epithelium takes place over 7 days.

O3 is a very strong oxidant, which has the ability to overwhelm the natural defences of the lungs. It induces lipid peroxidation and inactivation of biomolecules.

O3 potentially leads to the formation of secondary and tertiary reactive products [5], producing an immediate dose-dependant increase in intracellular reactive O2 species. Moreover, O3 activates stress signalling pathways in epithelial cells [6] and interacts with nuclear factor (NF)-{kappa}B [7]. The antioxidants, ascorbic acid, uric acid and glutathione, are the first lines of defence in the epithelial lining fluid.

O3 also increases the permeability of epithelial cells, favouring the entry of inhaled allergens and toxins and a subsequent release of inflammatory cytokines (interleukin (IL)-1, IL-6, IL-8 and tumour necrosis factor (TNF)). In an animal study, mucociliary clearance times decreased as O3 increased [8], causing susceptibility to bacterial respiratory infections. Furthermore, O3 induces decrements in pulmonary function, increasing airway responsiveness and resistance and altering lung volumes and flow.

Recently, the effect of ambient O3 concentrations on human health has been heavily studied. There is now overwhelming evidence showing associations between the levels of this pollutant and adverse respiratory effects, such as decrements in lung function, aggravation of pre-existing respiratory disease, increase in hospital admission and premature respiratory deaths [9, 10].

Several studies suggest that O3 increases asthma morbidity by enhancing airway inflammation, as demonstrated by the increase of IL-6, IL-8, granulocyte macrophage colony stimulating factor (GM-CSF) and fibronectin in bronchoalveolar lavage fluid (BALF) [11].

There are important individual differences in responsiveness to inhaled O3, as seen in mice [12, 13] and human subjects [14]. In particular, genes for TNF-{alpha}, glutathione peroxidase and manganese superoxide dismutase, emphasising the importance of lung antioxidants in protecting against O3 exposure [15], and the effects of a diet supplemented with antioxidants [16], have been studied.

Several studies show the effects of O3 on mortality. During the warm season, an increase in the 1-h O3 concentration by 10 µg·m–3 is associated with an increase of 0.33% in the total number of deaths daily, 0.45% in the number of cardiovascular deaths, and 1.13% in the number of respiratory deaths [17].


   NITROGEN DIOXIDE
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
NO2 derives from automobile exhaust and by the burning of fossil fuels. In conjunction with sunlight and hydrocarbons, it produces O3. NO2, like O3, is an oxidant pollutant but it is less potent and less reactive. The inflammatory response also differs, because there is the recruitment of T lymphocytes and macrophages [18]. Indoor NO2 is a major pollutant, especially in homes with gas stoves and kerosene space heaters. It has been associated with lower respiratory tract infections [19] and environmental air pollution, even if tobacco smoke is an important contributor to an individual's exposure. In normal subjects, inhalation of NO2 causes lung inflammation [20], reduces ascorbic and uric acid and increases glutathione, with no significant changes in lung function [21].

NO2 might contribute, moreover, to exacerbation of respiratory disease because of its capacity to impair the function of epithelial cells and alveolar macrophages [22]. However, findings are inconsistent due to difficulties in separating the effects of NO2 from those of co-pollutants [23].

Because of widespread indoor exposure, NO2 has been the focus of much attention in particular countries, such as in the UK where 50% of homes have gas cookers and millions of people are potentially exposed to indoor NO2 and its combustion by-products [24, 25]. Highly notable health effects have been demonstrated [26, 27]. In children exposed to a long-term increase of 30 µg·m–3 of NO2 (equivalent to having a gas cooker), a 29% increase in their risk of respiratory illness has been demonstrated [28].


   PARTICULATE MATTER
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
Airborne PM is a major component of urban air pollution. PM consists of a mixture of particle components, including traffic and combustion-derived carbon-centred ultrafine particles (<100 nm in diameter), secondary particles (nitrates and sulphates), wind-blown dust of geological origin potentially containing endotoxin, and biological particles (e.g. spores, pollen) with their associated allergens. PM that can reach the lower airways is called PM10 (the so called thoracic PM) and PM2.5, particles with an aerodynamic diameter <2.5 µm (the so called respirable PM).

Human lung parenchyma retains PM2.5 [29], while particles >5 and <10 µm reach the proximal airways and are eliminated by mucociliary clearance. PM is a highly toxic material because of its small size rather than its chemical composition, as suggested by the influx of inflammatory leukocytes into the airspaces [30]. PM has a variety of effects on lung defences. Transition metals contained in PM, in particular iron, damage the airways by generating free radicals and inducing oxidative stress [31]. The main cells involved in the initial pro-inflammatory responses to particles are the macrophages and epithelial cells. PM induces oxidative stress only in these cells [32].

The PM10 capacity of inducing oxidative stress in the airways has been proven in rats, by intratracheal instillation and subsequent increases in neutrophils in BALF, which is accompanied by decreased glutathione concentrations [33].

The oxidative effect of PM10 was confirmed, furthermore, by enhanced levels of NF-{kappa}B after mice were exposed to 300 µm–3 of PM2.5 [34]. This factor translocates to the nucleus where it binds to DNA consensus sequences in the promoters of proinflammatory genes that code for cytokines (GM-CFS, TNF-{alpha}) and chemokines (IL-8), thereby causing neutrophil recruitment and tissue damage.

A recent work has shown, in vivo, that after instillation of PM2.5 through a bronchoscope in healthy subjects there was an increase in radical oxidant generation and cytokine concentrations (IL-6 and TNF-{alpha}) in BALF [35]. This study, together with similar ones [36], demonstrates that chronically elevated levels of IL-6 and TNF-{alpha} may play a role in triggering allergic sensitisation.

The inflammatory effect of PM has been studied in mice, in which the inhalation of 300 µm–3 of PM2.5 causes increases in TNF-ß, IL-6, interferon-{gamma} and transforming growth factor-ß [37]. Furthermore, carbon particles, which are an important constituent of PM10, cause the release of immature neutrophils from the bone marrow [38], underlining the chief role of PM in the pathogenesis of chronic obstructive pulmonary disease (COPD).

Epidemiological evidence indicates a clear relationship between the levels of PM and increased morbidity, including respiratory symptoms, exacerbation of allergies, asthma, reduction in lung function and hospital admissions in patients with COPD. In Europe, the Air Pollution and Health: a European Approach (APHEA–2) studies demonstrated that hospital admissions for asthma and COPD increased by 1.0% per 10 µg·m–3 PM10 [39].

Diesel exhaust particulate (DEP) constitutes a large proportion of the PM in ambient air. In particular, diesel exhaust fumes causes bronchoconstriction, neutrophilic inflammation and dysfunction of alveolar macrophage phagocytosis, together with histamine release from mast cells in healthy individuals [40].

A few studies have shown the effect of DEP inhalation in asthmatic subjects [41]. An increased bronchial hyperresponsiveness and an enhanced allergen response were demonstrated after local diesel exhaust particle instillation in the nose [42].

The increase in the volume of road traffic and in air pollution shows a parallel increase in allergic disease, such as asthma and rhinitis. In fact, after inhaling DEP, the normal defence mechanism of the lung may be overwhelmed by the quantity or the toxicity of those particles. More specifically, the bronchial epithelium and cilia are damaged and the allergens remain on the epithelial surface for long time. Likewise, DEP may bind pollen or other allergens, thereby sensitising the airways to successive allergen exposure. Epidemiological studies have shown a significant association between a PM10 exposure and exacerbation of asthma in children and adults [43, 44].

In vivo murine models have shown an increased production in total and specific immunoglogulin (Ig)E after DEP injection [45], but also increased bronchial hyperresponsiveness and airway inflammation [46].

Studies of human exposure to DEP demonstrate acute inflammation in healthy subjects [47], and the DEP has an important pro-inflammatory effect of DEP in the upper airways, as suggested by the levels of cytokines in the nasal mucosa [48]. In vitro culture studies have concentrated on the mechanism by which PM10 causes airway damage and inflammation.

Apart from the large number of studies suggesting that DEP induces the production of inflammatory mediators and cytokines, the most recent studies have analysed the effects of suspended DEP on IL-8 gene expression [49], which is known to be a potent chemotactic factor for neutrophils, eosinophils and T-lymphocytes, and is undoubtedly an important factor in bronchial hyperresponsiveness. There is evidence that DEP induces oxidative stress in macrophages and bronchial epithelial cells by activation of NF-{kappa}B [50].

Other important in vitro studies have shown experimental evidence that DEP can cause an increase in the release of T-helper cell type 2 chemokines and IgE production from purified B-cells [51]. In addition, the capacity of DEP to activate p38 mitogen-activated protein kinases, which control the production of IL-8 and RANTES by human epithelial cells, has been shown [52].


   SULPHUR DIOXIDE
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
SO2 derives primarily from fuel combustion, mainly from industries and vehicle traffic, and is not an important indoor pollutant in terms of health. SO2 has been shown to produce reactive oxygen species in the lungs, but high concentrations are needed to cause important effects on the antioxidant mechanism. Asthmatics may be more susceptible than normal subjects to SO2 bronchoconstriction [53].

In contrast to O3, the bronchoconstriction caused by SO2 inhalation is immediate, and significant responses on lung function in asthmatic individuals are observed within 2 min [54].


   FORMALDEHYDE
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
HCHO occurs ubiquitously in the environment and is found in cigarette smoke, vehicle exhaust, in fruits, vegetables and other foods, in construction, furniture and cleaning agents. Although some studies have demonstrated the irritant effect of HCHO on the eyes, nose and throat, there is no evidence of any increase in respiratory symptoms or decreased lung function at current domestic levels in adults. One study demonstrates that asthma and bronchitis (but not other respiratory symptoms) are more prevalent among children living in houses with higher HCHO levels [55].


   OTHER VOLATILE ORGANIC COMPOUNDS
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
VOCs encompasses a wide range of hydrophilic or lipophilic substances of neutral, basic or acid character. They derive from building materials, paints, furniture, cleaning agents, resins etc. Active and passive cigarette smoking contribute to indoor concentrations. Many VOCs are irritants or narcotics and can cause depression of the central nervous system, but there is no association between VOC levels in the air and respiratory health [56].


   PASSIVE SMOKE EXPOSURE
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 
Tobacco smoke contains drops of tar and a mixture of other toxic elements, such as CO, NO, ammonia and proven animal carcinogens, such as polycyclic aromatic hydrocarbons and benzene. ETS has been classified as carcinogenic only in Germany [57]. The real mechanism of action of ETS is not well known, but it is recognised that tobacco smoke is a carcinogen, stimulates wheezing and sputum production, inhibits mucociliary clearance, causes inflammation of the airways and has a negative impact on lung defences [58]. It is difficult to estimate an individual's exposure to ETS because of other airborne contaminants. To assess exposure, it is possible to measure ETS metabolites, such as urinary or salivary cotinine, a metabolite of nicotine, or ETS directly, using questionnaires. A recent review found an association between passive smoke exposure and an increased risk of chronic bronchitis and asthma in young adults [59]. There is evidence of an association between ETS during childhood and respiratory symptoms [60].


   INDOOR ALLERGENS
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
CONCLUSION
 REFERENCES
 
The most important indoor allergens are dust mites, domestic pets, such as cats and dogs, mice, rats, insects, especially cockroaches and fungi. Their allergenic activity depends on the capacity of proteins to interact with IgE bound to fragment crystallisable receptors on basophils and mast cells and to trigger the release of cytokines and other mediators involved in inflammation. Indoor sensitisation is a risk factor for the development of asthma [61]. With increasing allergen exposure, asthma symptoms, bronchial reactivity and lung function all worsen in sensitised patients.

Indoor allergens have been implicated in increasing the severity and prevalence of asthma, but there is no evidence that allergen exposure can be the primary cause of asthma [62]. Several longitudinal studies have shown a strong association between allergen exposure early in life and the high probability of developing asthma [63].


   CONCLUSION
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
REFERENCES
 
The lungs have immunological mechanisms that are generally highly efficient at defending the entire organism. All the environmental factors examined in this article interact with lung defences, some of them stimulating (with increased inflammatory cytokines), while others inhibiting (with an alteration of the oxidant-antioxidant balance, or with a decreased mucociliary clearance), the normal defence mechanisms.

Inflammatory mechanisms are, by definition, defence mechanisms. Thus, airway inflammation means mucus hypersecretion, chemotaxis for inflammatory cells, and release of mediators that are potentially noxious for lung tissues and able to destroy the alveolar attachments and to modify the small airways structures. These changes are often seen in chronic respiratory disease, such as COPD, patients.

Immunological mechanisms are highly specific lung defences that integrate inflammatory processes. However, the immunological mechanism can be modified by environmental factors. Some air pollutants stimulate the release of TNF-ß and IL-6. When their levels remain chronically elevated, they can trigger allergic disease. The destruction of the bronchial epithelium and cilia by inhaled environmental factors permits the allergens to remain on the epithelial surface for a prolonged time, hence sensitising the subject. Also, the consequent increase of IgE is important in determining and maintaining bronchial hyperresponsiveness.

In summary, there is rarely a clear cause–effect relationship between environmental factors and lung disease [64] (table 2Go). However, air pollution certainly interferes with aspecific and specific lung defences, thus facilitating the development of pulmonary diseases.


View this table:
[in this window]
[in a new window]
  		TABLE 2— Effect on lung defences and association with lung disease

 


   REFERENCES
TOP
 ABSTRACT
 OZONE
 NITROGEN DIOXIDE
 PARTICULATE MATTER
 SULPHUR DIOXIDE
 FORMALDEHYDE
 OTHER VOLATILE ORGANIC COMPOUNDS
 PASSIVE SMOKE EXPOSURE
 INDOOR ALLERGENS
 CONCLUSION
 REFERENCES
 

  1. Brunekreef B, Holgate S. Air Pollution and Health. Lancet 2002; 360: 1233–1242.[Medline]
  2. Arden Pope III C. Air Pollution and Health – Good news and bad. N Engl J Med 2004; 351; 11: 1132–1134.
  3. Stone V. Environmental air pollution. Am J Respir Crit Care Med 2000; 162: 44–47.
  4. Olivieri D, Pesci A, Bertorelli G. Immunological defences in airways: from injury to repair. Lung Biology in Health and Disease. New York, Marcel Dekker inc 1996; 93: 43–69.
  5. Kelly FJ, Blomberg A, Frew A, Holgate ST, Sandstrom T. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Am J Respir Crit Care Med 1996; 1: 1700–1705.
  6. Bayram H, Sapsford RJ, Abdelaziz MM, Khair OA. Effect of ozone and nitrogen dioxide on the release of proinflammatory mediators from bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic asthmatic patients in vitro. J Allergy Clin Immunol 2001; 107: 287–294.[Medline]
  7. Nichols BG, Woods JS, Luchtel DL, Corral J, Koenig JQ. Effects of ozone exposure on nuclear factor-kappaB and tumour necrosis factor-alpha expression in human nasal epithelial cells. Toxicol Sci 2001; 60: 356–362.[Abstract/Free Full Text]
  8. Schlesinger RB, Driscoll KE. Mucociliary clearance from the lungs of rabbits following single and intermittent exposure to ozone. J Toxicol Health 1987; 20: 125–134.
  9. Thurston GD, Ito K. Epidemiological studies of ozone exposure effects. In: IIolgate ST, Samet JM, Koren IIS, et al. eds. Air pollution and health. London, Academic Press, 1999; 485–510
  10. MacNee W, Donaldson K. Exacerbation of COPD: environmental mechanism. Chest 2000; 117: 390–397.
  11. Balmes JR, Aris RM, Chen LL, et al. Effects of ozone on normal and potentially sensitive human subjects. Part I: airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Respir Rep Health Eff Inst 1997; 78: 1–37.
  12. Kleeberg SR, Levitt RC, Zhang LY, et al. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat Genet 1997; 17: 475–478.[Medline]
  13. Cho HY, Zhang LY, Kleeberg SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumour necrosis factor alpha receptor. Am J Physiol Lung Cell Mol Physiol 2001; 280: L537–L546.[Abstract/Free Full Text]
  14. Bergamaschi E, Palma G, Mozzoni P, et al. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am J Respir Crit Care Med 2001; 163: 1426–1431.[Abstract/Free Full Text]
  15. Mudway IS, Krishna MT, Frew AJ, et al. Compromised concentration of ascorbate in fluid lining the respiratory tract in human subjects after exposure to ozone. Occup Environ Med 1999; 56: 473–481.[Abstract]
  16. Samet JM, Hatch GE, Horstman D, et al. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med 2001; 164: 819–825.[Abstract/Free Full Text]
  17. Gryparis A, Forsberg B, Katsouyanni K, et al. Acute effects of ozone on mortality from the "air pollution and health: a European approach" project. Am J Respir Crit Care Med 2004; 170: 1080–1087.[Abstract/Free Full Text]
  18. Sandstrom T, Helleday R, Bjermer L, Stjernberg N. Effects of repeated exposure to 4 ppm nitrogen dioxide on bronchoalveolar lymphocyte subsets and macrophages in healthy men. Eur Respir J 1992; 5: 1092–1096.[Abstract]
  19. Speizer FE, Ferris Jr, Bisop YMM, Spengler J. Respiratory disease rates and pulmonary function in children associated with NO2 exposure. Am Rev Respir Dis 1980; 121: 3–10.[Medline]
  20. Blomberg A, Krishna MT, Bocchino V, et al. The inflammatory effects of 2 ppm NO2 on the airways of healthy subjects. Am J Respir Crit Care Med 1997; 156: 418–424.[Abstract/Free Full Text]
  21. Blomberg A. Airway inflammatory and antioxidant responses to oxidative and particulate air pollutants-experimental exposure studies. Clin Exp Allergy 2000; 30: 310–317.[Medline]
  22. Chauhan AJ, Krishna MT, Frew AJ, Holgate ST. Exposure to nitrogen dioxide and respiratory disease risk. Rev Environ Health 1998; 13: 73–90.[Medline]
  23. Sunyer J. Nitrogen dioxide: an important cause of health effects?. Eur Respir Rev 1998; 8: 139–140.
  24. Raw GJ, Coward SKD. Exposure to nitrogen dioxide in homes in the UK: a pilot study. In: Proceedings of Unhealthy Housing: the Public Health Response (December 1991). Warwick, Warwick University, 1992
  25. Ross D. Continuous and passive monitoring of nitrogen dioxide in UK homes. BRE Note N109/94. Watford, Building Research Establishment, 1994
  26. Ackermann-Liebrich U, Rapp R. Epidemiological studies of oxides of nitrogen, especially NO2. In: Holgate ST, Samet JM, Koren Hs, Maynard RL, eds. Air Pollution and Health. London, Academic Press, 1999; 559–584
  27. Dennekamp M, Howarth S, Dick CAJ, Cherry JW, Donaldson K, Seaton A. Ultrafine particles and nitrogen oxides generated by gas and electric cooking. Occup Environ Med 2001; 58: 511–516.[Abstract/Free Full Text]
  28. Hasselblad V, Eddy DM, Kotchmar DJ. Synthesis of environmental evidence: nitrogen dioxide epidemiology studies. J Air Waste Manage Assoc 1992; 42: 662–671.[Medline]
  29. Churg A, Brauer M. Human lung parenchyma retains PM 2.5. Am J Respir Critic Care Med 1997; 155: 2109–2111.[Abstract]
  30. Li XY, Gilmour PS, Donaldson K, et al. Free-radical activity and pro-inflammatory effects of particulate air pollution in vivo and in vitro. Thorax 1996; 51: 1216–1222.[Abstract]
  31. Smith KR, Aust AE. Mobilization of iron from urban particulates leads to generation of reactive oxygen species in vitro and induction of ferritin synthesis in human lung epithelial cells. Chem Res Toxicol 1997; 10: 828–834.[Medline]
  32. Goldsmith CA, Frevert C, Imrich A, Sioutas C, Kobzik L. Alveolar macrophage interaction with air pollution particulates. Environ Health Perspect 1997; 105: 1191–1195.
  33. Li XY, Gilmour PS, Donaldson K, Mac Nee W. Free radical activity and pro-inflammatory effects of particulate air pollution (PM 10) in vivo and in vitro. Thorax 1996; 51: 1216–1222.[Abstract]
  34. Shukla A, Timblin C, Berube K, et al. Inhaled particulate matter causes expression of nuclear factor (NF)-kappa B-related genes and oxidant-dependent NF-kappaB activation in vitro. Am J Respir Cell Mol Biol 2000; 23: 182–187.[Abstract/Free Full Text]
  35. Shaumann F, Borm P, Herbrich A, et al. Metal-rich ambient particles cause airway inflammation in healthy subjects. Am J Crit Care Med 2004; 170: 898–903.[Abstract/Free Full Text]
  36. Ghio AJ, Devlin RB. Inflammatory lung injury after bronchial instillation of air pollution particles. Am J Respir Crit Care Med 2001; 164: 704–708.[Abstract/Free Full Text]
  37. Shukla A, Timblin C, Berube K, et al. Inhaled particulate matter causes expression of nuclear factor kappa-B related genes and oxidant-dependant NF-kappaB activation in vitro. Am J Respir Cell Mol Biol 2000; 23: 182–187.
  38. Tershima T, Wiggs B, English D, et al. Phagocytosis of small carbon particles by alveolar macrophages stimulates the release of polymorphonuclear leukocytes from bone marrow. Am J Respir Crit Care Med 1997; 155: 1441–1447.[Abstract]
  39. Atkinson RW, Anderson HR, Sunyer J, et al. Acute effects of particulate air pollution on respiratory admissions: result from APHEA 2 project. Air Pollution and Health: a European approach. Am J Respir Crit Care Med 2001; 164: 1860–1866.[Abstract/Free Full Text]
  40. Sydbom A, Blomberg A, Parnia S, Stenfors N, Sandstrom T, Dahlèn SE. Health effects of diesel exhaust emissions. Eur Respir J 2001; 17: 733–746.[Abstract/Free Full Text]
  41. Nordenhall C, Pourazar J, Ledin M-C, Levin J-O, Sandstrom T, Adelroth E. Exposure to diesel exhaust enhances airway responsiveness in asthmatic subjects. Eur Respir J 2001; 17: 909–915.[Abstract/Free Full Text]
  42. Diaz-Sanchez D, Tsien A, Cacillas A, Dotson Ar, Saxon A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996; 98: 114–123.[Medline]
  43. Peters A, Dockery DW, Heinrich J, Wichmann HE. Short-term effects of particulate air pollution on respiratory morbidity in asthmatic children. Eur Resp J 1997; 10: 872–879.[Abstract]
  44. Walter S, Miles J, Ayres J, Archer G. Effect of an air pollution episode on respiratory functions on patients with asthma. Thorax 1993; 48: 1063
  45. Muranaka M, Suzuki S, Koizumi K, et al. Adjuvant activity of diesel-exhaust particulates for the production of IgE antibody production in mice. J Allergy Clin Immunol 1986; 77: 616–623.[Medline]
  46. Takano H, Ichinose T, Miyabara Y, et al. Inhalation of diesel exhaust enhances allergen-related airway hyperresponsiveness in mice. Int Arch Allergy Immunol 1998; 116: 124–131.[Medline]
  47. Nightingale JA, Maggs R, Cullinan P, et al. Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med 2000; 162: 161–166.[Abstract/Free Full Text]
  48. Diaz-Sanchez D, Tsien A, Casillas A, Dotson AR, Saxon A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996; 98: 114–123.
  49. Takizawa H, Ohtoshi T, Kawasaki S, et al. Diesel exhaust particles induce NF-kappa B activation in human bronchial epithelial cells in vitro: importance in cytokine transcription. J Immunol 1999; 162: 4705–4711.[Abstract/Free Full Text]
  50. Nel AE, Diaz Sanchez D, Li N. The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr Opin Pulm Med 2001; 7: 20–26.[Medline]
  51. Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol 1995; 95: 103–115.[Medline]
  52. Hashimoto S, Gon Y, Yakeshita I, et al. Diesel exhaust particles activate p38 MAP kinase to produce interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine attenuates p38 MAP kinase activation. Am J Respir Crit Care Med 2000; 161: 280–285.[Abstract/Free Full Text]
  53. Schesinger RB. Toxicity of sulfur oxides. In: Holgate ST, Samet JM, Koren HS, Maynard RL, eds. Air Pollution and Health. London, Academic Press, 1999; 585–602
  54. Balmes JR, Fine JM, Sheppard D. Symptomatic bronchoconstriction after short-term inhalation of sulphur dioxide. Am Rev Respir Dis 1987; 136: 1117–1121.[Medline]
  55. Krzyzanowski M, Quackenboss JJ, Lebowitz MD. Chronic respiratory effects of indoor formaldeyde in healthy subjects. Arch Envir Health 1986; 41: 229–239.[Medline]
  56. Harving H, Dahl R, Molhave L. Lung function and bronchial reactivity in asthmatic during exposure to volatile organic compounds. Am Rev Respir Dis 1991; 143: 751–754.[Medline]
  57. Arbeitsstattenverordnung. Verordnung uber Arbeitsstatten, 2001. http://de.osha.eu.int/legislation/VERORD/arbeitsstaetten.html. Date accessed: August 16, 2002
  58. Maroni M, Seifert B, Lindvall T. Indoor air quality - A Comprehensive Reference Book. Amsterdam, Elsevier, 1995
  59. Radon K, Busching K, Heinrich J, et al. Passive smoking exposure- a risk factor for chronic bronchitis and asthma in adults?. Chest 2002; 122: 1086–1090.[Abstract/Free Full Text]
  60. Gold DR. Environmental tobacco smoke, indoor allergens and childhood asthma. Environ Health Perspect 2001; 108: 643–651.
  61. Sporik R, Platts-Mills TA, Cogswell JJ. Exposure to house dust mite allergen of children admitted to hospital with asthma. Clin Exp Allergy 1993; 23: 740–746.[Medline]
  62. Lau S, Illi S, Sommerfeld C, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre allergy study group. Lancet 2000; 356: 1392–1397.[Medline]
  63. Litonjua AA, Carey VJ, Burge HA, Weiss ST, Gold DR. Exposure to cockroach allergen in the home is associated with incident doctor-diagnosed asthma and recurrent wheezing. J Allergy Clin Immunol 2001; 107: 41–47.[Medline]
  64. Del Donno M, Verduri A, Olivieri D. Air pollution and reversible chronic respiratory disease. Monaldi Arch Chest Dis 2002; 57; 3–4: 164–166.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivieri, D.
Right arrow Articles by Scoditti, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olivieri, D.
Right arrow Articles by Scoditti, E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS